Objective To explore the effect of Liraglutide(Lir)combined with intravenous thrombolysis on neurological function and prognosis in acute cerebral infarction patients with type 2 diabetes mellitus(T2DM).Methods Totally 137 acute cerebral infarction patients with T2DM were randomly divided into Lir group(69 cases)and Ins group(68 cases).The Ins group was treated with insulin aspart combined with insulin glargine,while the Lir group was treated with Lira combined with insulin glargine.The scores of National Institutes of Health stroke scale(NIHSS)and modified Rankin scale(mRS)were compared between the two groups before and 3 months after treatment.Outpatient follow-up of the two groups was performed to record the recurrence of cerebral infarction and the time.Results After treatment,the scores of NIHSS[(6.51±1.91)vs(8.77±2.03)]and mRS[(2.07±0.58)vs(2.44±0.78)]of Lir group were lower than Ins group(P<0.05).The recurrence risk of cerebral infarction in Lir group was lower than that in Ins group(6.5%vs 22.1%,P<0.05).Conclusions The treatment of Lir combined with intravenous thrombolysis can effectively reduce neurological deficits and the recurrence risk in acute cerebral infarction patients with T2DM.

Objective To explore the effect of Liraglutide(Lir)combined with intravenous thrombolysis on neurological function and prognosis in acute cerebral infarction patients with type 2 diabetes mellitus(T2DM).Methods Totally 137 acute cerebral infarction patients with T2DM were randomly divided into Lir group(69 cases)and Ins group(68 cases).The Ins group was treated with insulin aspart combined with insulin glargine,while the Lir group was treated with Lira combined with insulin glargine.The scores of National Institutes of Health stroke scale(NIHSS)and modified Rankin scale(mRS)were compared between the two groups before and 3 months after treatment.Outpatient follow-up of the two groups was performed to record the recurrence of cerebral infarction and the time.Results After treatment,the scores of NIHSS[(6.51±1.91)vs(8.77±2.03)]and mRS[(2.07±0.58)vs(2.44±0.78)]of Lir group were lower than Ins group(P<0.05).The recurrence risk of cerebral infarction in Lir group was lower than that in Ins group(6.5%vs 22.1%,P<0.05).Conclusions The treatment of Lir combined with intravenous thrombolysis can effectively reduce neurological deficits and the recurrence risk in acute cerebral infarction patients with T2DM.

Objective To investigate the changes of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) and omentin-1 in patients with H-type hypertension complicated with acute ischemic stroke, and to analyze the correlation of sLOX-1 and omentin-1 levels with the severity and prognosis of the disease.Methods Totally 136 patients with H-type hypertension complicated with acute ischemic stroke from February2017 to May 2018 were selected as observation group, and 136 non-acute ischemic stroke patients with H-type hypertension in the same period as the control group. The patients of observation group were divided into mild, moderate and severe sub-groups according to NIHSS score, and they were also divided into good prognosis group and poor prognosis group based on modified RANKIN scale (mRS) score. The serum sLOX-1 and omentin-1 levels were detected, and the correlation of sLOX-1 and omentin-1 levels with severity and prognosis of disease was analyzed. Results The serum sLOX-1 level of the observation group was higher, but the serum omentin-1 level lower than that of control group (P < 0.05). With the severity of the disease, the serum sLOX-1 level increased, but the serum omentin-1 level decreased (P < 0.05). The serum sLOX-1 level of good prognosis group was significantly lower, whereas the serum omentin-1 level significantly higher than that of poor prognosis group (P < 0.05). sLOX-1 was positively correlated with NIHSS score and mRS score, while omentin-1 was negatively correlated with NIHSS score and mRS score (P < 0.05). Conclusions The levels of serum sLOX-1 and omentin-1 are closely related to the severity and prognosis of patients with H-type hypertension complicated with acute ischemic stroke, which could be used as markers for evaluating the severity and prognosis of the patients.